|
| Press Releases |
|
 |
|
| Thursday, September 8, 2022 |
|
|
Dammam Valley and Arcensus GmbH to establish Saudi-German Genomic Center in Riyadh |
| The Saudi-German Genomic Center will start operationally with immediate activity and provide comprehensive genomic diagnostic services for the GCC region based on exclusive next-generation sequencing technologies. more info >> |
|
|
Dammam Valley and Arcensus GmbH announce establishment of the Saudi-German Genomic Center in Riyadh |
| Dammam Valley in partnership with other investment partners, and Arcensus GmbH/Germany, announce the establishment of a high-throughput Saudi-German Genomic Center in Riyadh. more info >> |
|
| Monday, September 5, 2022 |
|
|
Dammam Valley to acquire majority in Arcensus GmbH; accelerating Whole Genome Sequencing in genetic diagnostics, delivering breakthrough technologies in genomic bioinformatics |
| Dammam Valley in partnership with other investment partners, announce to acquire a majority stake in Arcensus GmbH/Germany. Arcensus, founded by Dr. Arndt Rolfs, a multi-entrepreneur in biotechnology, CEO and founder of several innovative biotech companies, is a digital health and diagnostics company providing comprehensive genomic diagnostic services based on Whole Genome Sequencing. more info >> |
|
| Tuesday, February 22, 2022 |
|
|
MBMV invests in international bio-tech startup Arcensus GmbH |
| Based on Whole Genome Sequencing (WGS) Arcensus GmbH, Rostock/Berlin/New Jersey makes it possible to detect rare as well as frequent disorders such as cancer or heart diseases at the earliest stage in order to start preventive and personalized treatment. more info >> |
|
| Wednesday, January 12, 2022 |
|
|
Arcensus has appointed Prof. Dr. Arndt Rolfs as New CEO |
| Arcensus, a commercial-stage digital healthcare and diagnostics company that empowers people to take control of their health is pleased to announce that our Founder, Prof. Dr. Arndt Rolfs, a multi-entrepreneur in biotech and former CEO of several innovative biotech companies, including Nasdaq-listed company CENTOGENE, has been appointed as the Chief Executive Officer of Arcensus GmbH. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
TANAKA Develops World's First High-Performance Palladium Hydrogen Permeable Membrane Exhibiting High Hydrogen Purification Performance at Temperatures around 100 degrees C
Mar 5, 2026 22:00 JST
|
|
|
美國馬球協會擴大大學合作計畫 2026賽季隊伍數創紀錄達70支
Mar 5, 2026 20:00 HKT/SGT
|
|
|
美国马球协会扩大大学合作计划，2026赛季参赛队伍创纪录达70支
Mar 5, 2026 20:00 HKT/SGT
|
|
|
U.S. Polo Assn. Expands Collegiate Partnership Program to Record 70 Teams for 2026 Season
Mar 5, 2026 20:00 HKT/SGT
|
|
|
Lancaster Resources Announces Resignation of Penny White and the Addition of Rob Heaslop to the Board of Directors
Mar 5, 2026 17:29 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity
Mar 5, 2026 17:00: JST
|
|
|
CMS (867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity
Mar 5, 2026 16:00 HKT/SGT
|
|
|
Honda to Begin Sales of Two U.S.-built Vehicles in Japan
Mar 5, 2026 16:47 JST
|
|
|
DOCOMO's New Haptic-sharing System Enables Fans to Feel Closer to Idols
Mar 5, 2026 16:38 JST
|
|
|
Galaxy Corporation Leads "K-Entertech" IPO Rush as Nasdaq Vice Chairman's Surprise Visit Boosts Listing Prospects
Mar 5, 2026 15:30 HKT/SGT
|
|
|
康哲药业自研INHBE小核酸药物获批超重/肥胖临床
Mar 5, 2026 15:13 HKT/SGT
|
|
|
康哲藥業自研INHBE小核酸藥物獲批超重/肥胖臨床
Mar 5, 2026 15:02 HKT/SGT
|
|
|
Formerra 任命 Tom Kelly 為首席執行官
Mar 5, 2026 14:11 HKT/SGT
|
|
|
富士通Japan、大分市民図書館において「デジタル認証アプリ」を活用したWeb利用者登録サービスを構築し、運用を開始
Mar 5, 2026 13:25: JST
|
|
|
Honda、米国生産乗用車の日本導入を決定
Mar 5, 2026 12:50: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
